Every/DT
enhancer/NN
works/VBZ
with/IN
every/DT
promoter/NN
for/IN
all/PDT
the/DT
combinations/NNS
tested/VBN
:/:
could/MD
new/JJ
regulatory/JJ
pathways/NNS
evolve/VBP
by/IN
enhancer/NN
shuffling/NN
?/.

The/DT
promoters/NNS
and/CC
enhancers/NNS
of/IN
cell/NN
type-specific/JJ
genes/NNS
are/VBP
often/RB
conserved/VBN
in/IN
evolution/NN
,/,
and/CC
hence/RB
one/NN
might/MD
expect/VB
that/IN
a/DT
given/JJ
enhancer/NN
has/VBZ
evolved/VBN
to/TO
work/VB
best/RBS
with/IN
its/PRP$
own/JJ
promoter/NN
./.
=====
While/IN
this/DT
expectation/NN
may/MD
be/VB
realized/VBN
in/IN
some/DT
cases/NNS
,/,
we/PRP
have/VBP
not/RB
found/VBN
evidence/NN
for/IN
it/PRP
./.
=====
A/DT
total/NN
of/IN
27/CD
combinations/NNS
of/IN
different/JJ
promoters/NNS
and/CC
enhancers/NNS
were/VBD
tested/VBN
by/IN
transfection/NN
into/IN
cultured/VBN
cells/NNS
./.
=====
We/PRP
found/VBD
that/IN
the/DT
relative/JJ
efficiency/NN
of/IN
the/DT
enhancers/NNS
is/VBZ
approximately/RB
the/DT
same/JJ
,/,
irrespective/JJ
of/IN
the/DT
type/NN
of/IN
promoter/NN
used/VBN
,/,
i.e./FW
,/,
there/EX
was/VBD
no/DT
strong/JJ
preference/NN
for/IN
any/DT
given/JJ
enhancer/promoter/JJ
combination/NN
./.
=====
Notably/RB
,/,
we/PRP
do/VBP
not/RB
see/VB
particularly/RB
strong/JJ
transcription/NN
when/WRB
the/DT
immunoglobulin/NN
kappa/NN
enhancer/NN
(/(
or/CC
the/DT
immunoglobulin/NN
heavy/JJ
chain/NN
enhancer/NN
)/)
is/VBZ
used/VBN
to/TO
activate/VB
a/DT
kappa/NN
gene/NN
promoter/NN
./.
=====
We/PRP
propose/VBP
that/IN
a/DT
generally/RB
permissive/JJ
enhancer/promoter/JJ
interaction/NN
is/VBZ
of/IN
evolutionary/JJ
benefit/NN
for/IN
higher/JJR
eukaryotes/NNS
:/:
by/IN
enhancer/NN
shuffling/NN
,/,
genes/NNS
could/MD
be/VB
easily/RB
brought/VBN
under/IN
a/DT
new/JJ
type/NN
of/IN
inducibility/cell/NN
type/NN
specificity/NN
./.